StockData
Fortress Biotech, Inc. logo

Fortress Biotech, Inc. (FBIO) income statement

FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$1.89+0.07 (+3.85%)

Close on Nov 18, 2026Market cap $69.51MP/E –Yield –

Fortress Biotech, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
65.6%
Operating margin
-42.9%
Net margin
163.3%
Return on equity, FY2025
18.8%

Financial strength

Current ratio
3.96
Debt to equity
0.21
Debt to assets
10.9%
Cash to current liabilities
317.0%

Valuation

P/E ratio
–
Price to sales
1.02
Price to book
0.42
Dividend yield
–

See a number that looks wrong?